How much does TRT cost in 2026, and what does insurance cover?

Almost everyone pricing out testosterone therapy starts with the same question and makes the same mistake. The question is fair, “what will this cost me?”, but the mistake is treating an advertised monthly number as the answer. The price of TRT is really the price of everything wrapped around the medication: the evaluation, the lab monitoring, the dose management, and whether any of it runs through insurance. This guide lays out what published cost research found, where the money goes, and what men on therapy say about the bill.

How much does TRT cost?

How much TRT costs depends far more on the care model than on the testosterone. A cost analysis published in The Journal of Sexual Medicine priced 12 months of injectable testosterone through three direct-to-consumer telehealth platforms at $1,586 to $4,200, roughly $132 to $350 a month, while the same year at a tertiary care center, estimated with one institution’s online cost estimator, came to $134.01 to $1,333.04 depending on whether the patient had no insurance, private insurance or Medicare (Jesse et al., J Sex Med 2022). The authors found the platforms largely followed guidelines for evaluation and follow-up; the difference was the cost of ongoing treatment. Ongoing treatment with transdermal (gel) testosterone was likewise more expensive through the platforms in that analysis.

Source: Jesse et al., J Sex Med 2022. The prices were gathered for a study published in 2022, so treat them as a reference range, not a 2026 quote.

How much is TRT per year, and why is the first year the most expensive?

The first year of TRT usually costs the most because monitoring is front-loaded. The Endocrine Society calls for checking testosterone and hematocrit around three to six months after starting and then annually, with a prostate check (PSA and exam) 3 to 12 months after starting (Endocrine Society Clinical Practice Guideline), and the AUA recommends rechecking testosterone every 6 to 12 months once a man is on therapy (AUA Testosterone Deficiency Guideline). That early stretch of dose adjustment and extra labs is where much of the first-year spend goes. In maintenance years the number of draws and visits drops, so the long-run cost drifts lower. When you compare programs, ask what a typical maintenance year looks like, not only the introductory offer.

Where does the money go?

A TRT bill pays for much more than the testosterone. The table below lists each line item, what drives its cost, and whether it counts as a qualified medical expense for HSA or FSA spending.

Lab contents follow the AUA guideline and the Endocrine Society guideline; ancillary options follow a peer-reviewed review on preserving fertility in hypogonadal men; the eligibility column follows IRS Publication 502, which lists prescribed medicines, laboratory fees and physician services as qualified medical expenses. For what a good baseline panel includes, see our guide to blood tests before starting TRT.

Why does the care model change the price so much?

The same injectable testosterone can carry very different yearly prices depending on who delivers it. The Journal of Sexual Medicine analysis estimated 12 months of intramuscular treatment at a tertiary center from $134.01, depending on insurance, against $1,586 or more through the telehealth platforms it priced (Jesse et al., J Sex Med 2022). At any price, the care should include a clinician checking testosterone levels on therapy and watching hematocrit and PSA (AUA Testosterone Deficiency Guideline). Formulation also matters. In a survey of men on TRT at an academic urology clinic, 35% of men on injections said lower cost was a reason for their choice, compared with 21% of gel users and 19% of pellet users (Kovac et al., J Sex Med 2014).

Is TRT covered by insurance?

It can be, when it treats a documented diagnosis, but coverage comes with conditions. As one published example, Blue Cross Blue Shield of Michigan’s medical drug policy for two long-acting products, Aveed and Testopel, covers them when there is a diagnosis of male hypogonadism and documentation of at least two signs or symptoms of testosterone deficiency, and only after a trial and failure of (or a reason not to use) generic injectable testosterone. Approval runs one year at a time, with renewal requiring documentation that the medication is providing clinical benefit (BCBSM Testosterone Replacement Products policy, Dec 2025). Other plans and other products have their own criteria, so check yours. In the Journal of Sexual Medicine analysis, the telehealth prices came from each platform’s website, while insurance scenarios were estimated only for the tertiary center (Jesse et al., J Sex Med 2022).

How much is TRT with insurance?

With insurance, TRT can cost far less than a cash program, but only if your plan covers it. In the published comparison, the estimate for a year of injectable treatment at a tertiary center ranged from $134.01 to $1,333.04 across no insurance, private insurance and Medicare, and the authors advised that patients with private insurance or Medicare should expect ongoing telehealth treatment to cost more than care at a center that can use their coverage (Jesse et al., J Sex Med 2022). The study’s center estimates covered only one type of private and one type of public insurance, so your deductible, copays and any step rules like the generic-injection-first requirement above will set your own number.

How much is TRT without insurance?

Without insurance, you pay every line item yourself, and the care model sets the total. The telehealth platforms in the published analysis charged $1,586 to $4,200 for a year of injectable treatment (Jesse et al., J Sex Med 2022), and the uninsured estimate at the tertiary center fell within the $134.01 to $1,333.04 range the study reported across insurance types. An HSA or FSA softens the bill either way: prescribed testosterone, provider evaluation and laboratory work for a diagnosed condition are qualified medical expenses (IRS Publication 502), and HSAs and health FSAs pay those expenses with pre-tax or tax-free dollars (IRS Publication 969). Ask any program for an itemized superbill so you can seek partial reimbursement for the medical components.

How is TRT priced?

There are three common pricing structures, and the one you choose changes your total more than any single line item. A cash membership bundles the visit, medication and monitoring into one flat monthly or quarterly fee. The traditional route has an in-network endocrinologist or urologist bill your plan for visits, labs and the prescription separately. A hybrid charges a modest program fee but sends prescriptions to your pharmacy and labs to a facility that can bill your insurer. In the published comparison, a year of care at a tertiary center came out cheaper than the telehealth platforms in all three insurance scenarios it estimated, including no insurance (Jesse et al., J Sex Med 2022). For pricing that is specific to online programs, see our breakdown of how much TRT costs through telehealth.

What do ancillary drugs and extras add?

Ancillary prescriptions add line items of their own. Men who want to protect fertility may be treated with hCG or clomiphene/enclomiphene, sometimes alongside an aromatase inhibitor such as anastrozole, and each carries its own price and monitoring (peer-reviewed review: preserving fertility in the hypogonadal patient). Add-ons are also something online programs actively offer: in a 2022 secret shopper study of seven telehealth testosterone platforms, the shopper was offered a broad range of off-label medications alongside testosterone, including anastrozole, hCG and clomiphene (Dubin et al., JAMA Intern Med 2022). Ask which extras your labs actually call for before they become a monthly charge.

What are the side effects you are paying to monitor?

The monitoring in a TRT fee exists because the therapy has real risks. The JAMA Internal Medicine authors describe testosterone as associated with increased risk of infertility, polycythemia (thickened blood) and possibly cardiovascular events (Dubin et al., JAMA Intern Med 2022). That is why guidelines call for hematocrit and PSA checks at baseline and follow-up (AUA Testosterone Deficiency Guideline; Endocrine Society Clinical Practice Guideline). A price that leaves out labs is leaving out the safety net, not a markup. Our page on TRT safety questions goes through what those checks catch, from blood pressure to sleep apnea and hematocrit.

How do you tell a good deal from a red flag?

A price that looks too good usually signals what has been removed. The 2022 secret shopper study is a useful checklist of what to watch for: the shopper, whose total testosterone was in the normal range at 675 ng/dL and who said he wanted future fertility, was offered testosterone by 6 of 7 platforms; only 1 of 7 asked about recent cardiovascular events or fertility plans; 3 of the 6 that offered treatment set a target of 1,000 ng/dL or more and did not discuss fertility risks; and 5 of 6 did not discuss the risk of polycythemia (Dubin et al., JAMA Intern Med 2022). Green flags are the opposite: two early-morning testosterone measurements before diagnosis, baseline hematocrit, and PSA in men over 40 (AUA Testosterone Deficiency Guideline), a named licensed clinician, and a fee that states plainly which labs and visits it includes.

What do men on TRT say about the cost?

Men on therapy weigh cost alongside convenience, and most report being satisfied. In an anonymous survey of 382 men on TRT at an academic urology clinic (average age 49), 53% used injections, 31% gels and 17% pellets; 70% said they were satisfied with treatment and 14% dissatisfied (Kovac et al., J Sex Med 2014). Cost mattered most to injection users: 35% named lower cost as a reason for their choice, versus 21% of gel users and 19% of pellet users. Pellet users, who pay more for less frequent treatment, chose them for ease of use (64%) and convenience (58%).

Source: Kovac et al., J Sex Med 2014.

Why is everyone talking about what TRT costs right now?

More men have a testosterone prescription than a few years ago, and social media is selling it hard. Epic Research, studying 109 million men aged 18 and older with a health care visit between 2012 and mid-2026, found the share with a testosterone prescription fell from 0.83% in 2013 to 0.64% in 2021, then climbed to 0.93% in 2025 and 0.95% by mid-2026; men aged 50 to 64 had the highest rate, 1.57% in 2025 (Epic Research, July 2026). The online conversation is louder than the clinical one. A University of Sydney study, published in Social Science & Medicine, of 46 high-reach Instagram and TikTok posts promoting testosterone tests and treatment, from accounts with a combined 6.8 million followers, found none cited scientific evidence, 67% included direct purchase links and 72% had a financial interest such as selling tests, supplements or clinic consultations (University of Sydney, Feb 2026). When a “what does TRT cost” video ends in a promo code, read the price as marketing.

How does TRT cost compare with the alternatives?

Over-the-counter testosterone boosters are a different category of product from TRT, with no clinician monitoring; our comparison of TRT vs testosterone boosters covers what the evidence shows for each. Fertility-sparing approaches such as hCG or clomiphene/enclomiphene carry their own medication and monitoring costs (peer-reviewed review: preserving fertility in the hypogonadal patient). If you are also weighing peptide or GLP-1 programs, the hub’s peptide and GLP-1 therapy cost explainer covers that side of the bill. And if the comparison you have in mind is non-prescribed steroids, our page on whether TRT is a steroid explains why the monitoring is the part those cycles skip.

The bottom line

What TRT costs comes down to the care model, your insurance and the monitoring your labs call for, more than to the testosterone itself. Symptomatic low testosterone is associated with reduced energy, low mood, loss of muscle and reduced libido (AUA Testosterone Deficiency Guideline), but many of the same complaints have other causes, which is why labs and an evaluation come before any price comparison. A licensed provider decides whether therapy fits after reviewing that bloodwork and your history.

Sources

Clinical statements trace to medical-society guidelines and peer-reviewed studies; cost, coverage and tax statements trace to the published analyses, the insurer policy and the IRS publications below.

Cost and coverage

• Jesse E, et al. Practice Comparison and Cost Analysis of Direct-to-Consumer Telemedicine Platforms Offering Testosterone Therapy (J Sex Med, 2022), 12-month injectable testosterone cost of $1,586 to $4,200 via three telehealth platforms vs $134.01 to $1,333.04 at a tertiary center across no insurance, private insurance and Medicare.
• Blue Cross Blue Shield of Michigan, Testosterone Replacement Products medical policy (P&T date Dec 4, 2025), coverage criteria, generic-first step for Aveed and Testopel, one-year authorization and renewal criteria.
• IRS Publication 502, Medical and Dental Expenses, prescribed medicines, laboratory fees and physician services are qualified medical expenses.
• IRS Publication 969, Health Savings Accounts and Other Tax-Favored Health Plans, HSAs and health FSAs pay qualified medical expenses with pre-tax or tax-free dollars.

Clinical guidelines and literature

• AUA, Evaluation and Management of Testosterone Deficiency Guideline, diagnosis on two early-morning total-testosterone measurements, baseline hematocrit and PSA, testosterone rechecked every 6 to 12 months, and symptoms associated with testosterone deficiency.
• Endocrine Society, Testosterone Therapy in Men With Hypogonadism: Clinical Practice Guideline (J Clin Endocrinol Metab, 2018), monitoring at 3 to 6 months after initiation and then annually.
• Preserving fertility in the hypogonadal patient: an update (peer-reviewed review, PMC), hCG, enclomiphene/clomiphene and aromatase-inhibitor options.
• Dubin JM, et al. Guideline-Discordant Care Among Direct-to-Consumer Testosterone Therapy Platforms (JAMA Intern Med, 2022), secret shopper evaluation of seven platforms.

What men report and the wider conversation

• Kovac JR, et al. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices (J Sex Med, 2014), survey of 382 men on TRT.
• Epic Research, After Nearly a Decade-Long Decrease, Testosterone Prescribing Rates Rising Again (July 2026), testosterone prescription prevalence 2012 to mid-2026.
• University of Sydney, Influencers on social media promote low testosterone to young men, study finds (Feb 2026), analysis of 46 Instagram and TikTok posts published in Social Science & Medicine.